retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Retatrutide Phase 3: 28.7% Weight
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10























